Team:ITU MOBGAM Turkey/Safety

From 2013.igem.org

(Difference between revisions)
(Prototype team page)
Line 1: Line 1:
-
<!-- *** What falls between these lines is the Alert Box!  You can remove it from your pages once you have read and understood the alert *** -->
 
-
 
<html>
<html>
-
<div id="box" style="width: 700px; margin-left: 137px; padding: 5px; border: 3px solid #000; background-color: #fe2b33;">
+
<head>
-
<div id="template" style="text-align: center; font-weight: bold; font-size: large; color: #f6f6f6; padding: 5px;">
+
 
-
This is a template page. READ THESE INSTRUCTIONS.
+
<title>ITU IGEM</title>
 +
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
 +
<link rel="shortcut icon" href="favicon.ico">
 +
<script type='text/javascript' src='http://igem.itu.edu.tr/js/bootstrap.js'></script>
 +
<script src='http://igem.itu.edu.tr/js/jquery-2.0.3.min.js'></script>
 +
<script src='http://igem.itu.edu.tr/js/bootstrap.min.js'></script>
 +
<link href="http://igem.itu.edu.tr/css/igem.css" rel="stylesheet">
 +
<a href='https://2013.igem.org' style='float: left;'><h2 class='leftimg'><img src='http://igem.itu.edu.tr/images/igem.gif' /></a></h2>
 +
 
 +
</head>
 +
<body style='width:1300px; margin:0 auto;'>
 +
<!-- Google Analytics Tracking Code -->
 +
<script>
 +
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
 +
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
 +
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
 +
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');
 +
 
 +
  ga('create', 'UA-43967326-1', 'itu.edu.tr');
 +
  ga('send', 'pageview');
 +
 
 +
</script>
 +
 
 +
 
 +
<div class='container'>
 +
 
 +
<img src="http://igem.itu.edu.tr/images/carousel3.jpg" height="300px"/>
 +
 
 +
<div class='navbar' id='menu'> 
 +
  <div class='navbar-inner'>   
 +
      <ul class='nav'>
 +
        <li><a href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey' accesskey='1'>Home</a></li> 
 +
        <li class='dropdown'>
 +
            <a href='#' class='dropdown-toggle' data-toggle='dropdown' data-hover='dropdown' data-delay='500' data-close-others='true'> Team <b class='caret'></b></a>
 +
      <ul class='dropdown-menu'>
 +
        <li><a tabindex='-1' href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/team'> Our Team </a></li>
 +
        <li><a tabindex='-1' href='https://igem.org/Team.cgi?id=1096'> Official Team Profile </a></li>
 +
      </ul>
 +
</li>
 +
 
 +
<li class='dropdown'>
 +
<a href='#' class='dropdown-toggle' data-toggle='dropdown' data-hover='dropdown' data-delay='500' data-close-others='true'> Project <b class='caret'></b></a>
 +
<ul class='dropdown-menu'>
 +
<li><a tabindex='-1' href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/project'> Intrinsic Factor-y </a></li>
 +
<li><a tabindex='-1' href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/modelling'> Modelling </a></li>
 +
<li><a tabindex='-1' href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/parts'> Parts </a></li>
 +
</ul>
 +
</li>
 +
    <li><a href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/humanpractise' accesskey='8'>Human Practice</a></li>
 +
<li class='dropdown'>
 +
<a href='#' class='dropdown-toggle' data-toggle='dropdown' data-hover='dropdown' data-delay='500' data-close-others='true'> Notebook <b class='caret'></b></a>
 +
<ul class='dropdown-menu'>
 +
<li><a tabindex='-1' href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/protocol'> Protocols </a></li>
 +
<li><a tabindex='-1' href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/labdiary'> Laboratory Diary </a></li>
 +
</ul>
 +
<li><a href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/safety' accesskey='7'>Safety</a></li>
 +
        <li class='dropdown'>
 +
  <a href='#' class='dropdown-toggle' data-toggle='dropdown' data-hover='dropdown'> Attributions <b class='caret'></b></a>
 +
<ul class='dropdown-menu'>
 +
<li><a tabindex='-1' href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/collaborations'> Collaborations </a></li>
 +
<li><a tabindex='-1' href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/sponsors'> Sponsors </a></li>
 +
<li><a tabindex='-1' href='https://2013.igem.org/Team:ITU_MOBGAM_Turkey/acknowledgements'> Acknowledgements </a></li>
 +
</ul>
 +
</li> </ul>
 +
</div>  </div></div>
 +
 
 +
<div id="bg">
 +
  <div id="page">
 +
    <!-- end #content -->
 +
    <div id="body">
 +
      <div id="content">
 +
        <h1>&nbsp;</h1>
 +
        <h1>Safety</a></h1>
 +
 
 +
<p><strong>iGEM Safety Form</strong></p>
 +
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As ITU_MOBGAM_Turkey team, safety concerns is our first priority in both developing project and producing the prototype bacteria. Project is developed considering the BSL of our facility which is 1.  Member of laboratory crew has been selected on experience. Holding at least one month laboratory experience was criteria for selection.  MSDS files of chemicals were studied before using. All experiment carried in a convenient place (laminar hood, regular hood etc.). Waste both biological and organic materials were handled properly.</p>
 +
<p><strong>Offical Safety Form</strong></p>
 +
<p><strong>1. Please describe the chassis organism(s) you will be using for this project. If you will be using more than one chassis organism, provide information on each of them:</strong></p>
 +
<table border="1">
 +
<tr>
 +
<td><p><strong>Species</strong></p></td>
 +
<td><p><strong>Strain No</strong></p></td>
 +
<td><p><strong>Risk Group</strong></p></td>
 +
<td><p><strong>Risk Group Source Link</strong></p></td>
 +
<td><p><strong>Disease risk to humans? If so, which disease?</strong></p></td>
 +
</tr>
 +
<tr>
 +
<td><p> E.coli </p></td>
 +
<td><p> Bl21 (DE3) </p></td>
 +
<td><p> 1 </p></td>
 +
<td><p> http://oba.od.nih.gov<br>
 +
/oba/rac/Guidelines/<br>
 +
NIH_Guidelines.htm </p></td>
 +
<td><p> Yes. May cause irritation to skin, eyes and respiratory tract, may affect kidneys. </p></td>
 +
</tr>
 +
<tr>
 +
<td><p> E.coli </p></td>
 +
<td><p> (GM2163) </p></td>
 +
<td><p> 1 </p></td>
 +
<td><p> http://oba.od.nih.gov<br>
 +
/oba/rac/Guidelines/<br>
 +
NIH_Guidelines.htm </p></td>
 +
<td><p> Yes. May cause irritation to skin, eyes and respiratory tract, may affect kidneys. </p></td>
 +
</tr>
 +
</table>
 +
<br>
 +
<p><strong>2. List and describe all new or modified coding regions you will be using in your project. (If you use parts from the 2013 iGEM Distribution without modifying them, you do not need to list those parts.)</strong></p>
 +
<table border="1">
 +
<tr>
 +
<td><p><strong>Part Number</strong></p></td>
 +
<td><p><strong>Where did you get the physical DNA for this part (which lab, synthesis company, etc)?</strong></p></td>
 +
<td><p><strong>What species does this part originally come from?</strong></p></td>
 +
<td><p><strong>What is the Risk Group of the species?</strong></p></td>
 +
<td><p><strong>What is the function of this part, in its parent species?</strong></p></td>
 +
</tr>
 +
<tr>
 +
<td><p>BBa_K1096000</p></td>
 +
<td><p>Synthesized, Integrated DNA Technology</p></td>
 +
<td><p>Homo sapiens</p></td>
 +
<td><p>1</p></td>
 +
<td><p>Binds and transports the B12 vitamine in small intestine</p></td>
 +
</tr>
 +
<tr>
 +
<td><p>BBa_K1096001</p></td>
 +
<td><p>Synthesized, Integrated DNA Technology</p></td>
 +
<td><p>E. coli (K12)</p></td>
 +
<td><p>1</p></td>
 +
<td><p>Inhibits the toxic effect of MazF</p></td>
 +
</tr>
 +
<tr>
 +
<td><p>BBa_K1096002</p></td>
 +
<td><p>Synthesized, Integrated DNA Technology</p></td>
 +
<td><p>E. coli (K12)</p></td>
 +
<td><p>1</p></td>
 +
<td><p>mRNA endoribonuclease</p></td>
 +
</tr>
 +
</table>
 +
 +
<p><strong>Do the biological materials used in your lab work pose any of the following risks? Please describe.</strong></p>
 +
 
 +
<p><strong>&nbsp;&nbsp;&nbsp;a. Risks to the safety and health of team members or others working in the lab?</strong></p>
 +
 
 +
<p>NO.</p>
 +
 
 +
<p><strong>&nbsp;&nbsp;&nbsp;b. Risks to the safety and health of the general public, if released by design or by accident?</strong></p>
 +
 
 +
<p>NO.</p>
 +
 
 +
<p><strong>&nbsp;&nbsp;&nbsp;c. Risks to the environment, if released by design or by accident?</strong></p>
 +
 
 +
<p>Maybe. Transfer of MazE or MazF plasmid to other bacteria may affect survivability of other bacteria</p>
 +
 
 +
<p><strong>&nbsp;&nbsp;&nbsp;d. Risks to security through malicious misuse by individuals, groups, or countries?</strong></p>
 +
 
 +
<p>NO.</p>
 +
 
 +
<p><strong>5. If your project moved from a small-scale lab study to become widely used as a commercial/industrial product, what new risks might arise? (Consider the different categories of risks that are listed in parts a-d of the previous question.) Also, what risks might arise if the knowledge you generate or the methods you develop became widely available? (Note: This is meant to be a somewhat open-ended discussion question.)</strong></p>
 +
 
 +
<p>If the product become widely used in public, contamination may arise in environment due to the plasmid conjugation.</p>
 +
 
 +
<p><strong>6. Does your project include any design features to address safety risks? (For example: kill switches, auxotrophic chassis, etc.) Note that including such features is not mandatory to participate in iGEM, but many groups choose to include them.</strong></p>
 +
 
 +
<p>We have two kill switch mechanism for probable risk. One of them decrease risk of contamination of nature. Meanwhile, other one would inhibit overgrowth of bacteria we used.</p>
 +
 
 +
<p><strong>7. What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available.</strong></p>
 +
 
 +
<p>Yes. In our bachelor education we have a class name as 'Modern Techniques in Biology'. In that class, first lecture is biosafety training. However, the documents of the lecture is offline.</p>
 +
 
 +
<p><strong>8. Under what biosafety provisions will / do you work?</strong></p>
 +
 
 +
<p><strong>&nbsp;&nbsp;&nbsp;a. Please provide a link to your institution biosafety guidelines.</strong></p>
 +
 
 +
<p>NONE.</p>
 +
 
 +
<p><strong>&nbsp;&nbsp;&nbsp;b. Does your institution have an Institutional Biosafety Committee, or an equivalent group? If yes, have you discussed your project with them? Describe any concerns they raised with your project, and any changes you made to your project plan based on their review.</strong></p>
 +
 
 +
<p>No. However we discussed our project safety with our project instructor. We choose the strain of E. coli based on this because overgrowth of some strains of E. coli may fatal to human.</p>
 +
 
 +
<p><strong>&nbsp;&nbsp;&nbsp;c. Does your country have national biosafety regulations or guidelines? If so, please provide a link to these regulations or guidelines if possible</strong></p>
 +
 
 +
<p>http://www.turkted.org.tr/mevzuat/kanunlar/Bioguvenlik.htm  . The link provides you the biosafety law of Turkey but in turkish.</p>
 +
 
 +
<p><strong>&nbsp;&nbsp;&nbsp;d. According to the WHO Biosafety Manual, what is the BioSafety Level rating of your lab? (Check the summary table on page 3, and the fuller description that starts on page 9.) If your lab does not fit neatly into category 1, 2, 3, or 4, please describe its safety features [see 2013.igem.org/Safety for help].</strong></p>
 +
 
 +
 
 +
<p>&nbsp;&nbsp;&nbsp;Biosafety level 1.</p>
 +
 
 +
 
 +
      <h1>&nbsp;</h1>
 +
      </div>
 +
 +
<div id="extra">
 +
        <h2>&nbsp;</h2>
 +
        <h2><span class="title"><a></a></span></h2>
 +
<script src="http://widgets.twimg.com/j/2/widget.js"></script>
 +
        <p><a><img src="images/grafic2.gif" alt="" class="centerimg" height="80" width="80" /></a><a></a></p><script language="JavaScript1.1" type="text/javascript">
 +
 +
<!--
 +
quotes = new Array(11);
 +
quotes[0] = "“All the great revolutions in science start with an unexpected discrepancy that wouldn't go away.”" + "<br>- Matthew Strassler";
 +
quotes[1] = "“Science is the topography of ignorance.”" + "<br>-Oliver Wendell Holmes, Sr";
 +
quotes[2] = "“DNA is like a computer program but far, far more advanced than any software ever created.”" + "<br>- Bill Gates";
 +
quotes[3] = "“We're going to die, and that makes us the lucky ones.”" + "<br>- Richard Dawkins,";
 +
quotes[4] = "In nature nothing is created, nothing is lost, everything changes.”" + "<br>- Antoine-Laurent de Lavoisier";
 +
quotes[5] = "“The typical imperative from biology is not “Thou shalt... ,“ but “If ... then ... else.”" + "<br>- Steven Pinker";
 +
quotes[6] = "“Life is stranger than biology textbooks.”" + "<br>- David Rains Wallace";
 +
quotes[7] = "“Love, in its purest form, is biology.”" + "<br>- Ron Currie Jr";
 +
quotes[8] = "“Consciousness is the chronic pain of life, and all higher organisms suffer it every waking moment.”" + "<br>- David Marusek";
 +
quotes[9] = "“In Darwin's time all of biology was a black box: not only the cell, or the eye, or digestion, or immunity, but every biological structure and function because, ultimately, no one could explain how biological processes occurred.”" + "<br>-Michael Behe ";
 +
quotes[10] = "“Biology is the science. Evolution is the concept that makes biology unique.”" + "<br>-Jared Diamond ";
 +
quotes[11] = "“ Whether conservative or liberal, fundamentalist or agnostic, the more students learn of biology, the more they accept evolution.”" + "<br>-Kenneth R. Miller";
 +
quotes[12] = "“Nothing in biology makes sense except in the light of evolution.”" + "<br>-Theodosius Dobzhansky";
 +
quotes[13] = "“I believe God controls the universe. I don't believe biology works in an uncontrolled fashion.”" + "<br>-Richard Mourdock";
 +
 
 +
 
 +
//calculate a random index
 +
index = Math.floor(Math.random() * quotes.length);
 +
 
 +
//display the quotation
 +
document.write("<hr><H3>********* <br> " + "\"" + quotes[index] + "\"\n <br> ***********<\/H3>")
 +
document.write("");
 +
 
 +
// -->
 +
</script>
 +
<script src="http://widgets.twimg.com/j/2/widget.js"></script>
 +
<script>
 +
new TWTR.Widget({
 +
  version: 2,
 +
  type: 'profile',
 +
  rpp: 4,
 +
  interval: 6000,
 +
  width: 250,
 +
  height: 300,
 +
  theme: {
 +
    shell: {
 +
      background: '#3399FF',
 +
      color: '#000000'
 +
    },
 +
    tweets: {
 +
      background: '#ffffff',
 +
      color: '#000000',
 +
      links: '#0099FF'
 +
    }
 +
  },
 +
  features: {
 +
    scrollbar: false,
 +
    loop: false,
 +
    live: false,
 +
    hashtags: true,
 +
    timestamp: true,
 +
    avatars: false,
 +
    behavior: 'all'
 +
  }
 +
}).render().setUser('ituigem').start();
 +
</script>
 +
 
 +
<br><br>
 +
    <img src="images/contactus.jpg" width="80" height="80">
 +
        <strong>To contact us:</strong><br>
 +
<p> e-mail: igem.itu@gmail.com<br> 
 +
<a href="https://www.facebook.com/pages/ITU-IGEM-Team/234179823387406?ref=ts&fref=ts">Facebook</a><br>
 +
<a href="https://twitter.com/ituigem">Twitter</a></p>
 +
        <p>&nbsp;</p>
 +
 +
 +
      </div>
 +
 
 +
      <!--end extra-->
 +
    </div>
 +
    <!-- end #sidebar -->
 +
    <div style="clear: both; height: 20px;">&nbsp;</div>
 +
  </div>
 +
  <!-- end #page -->
</div>
</div>
-
<div id="instructions" style="text-align: center; font-weight: normal; font-size: small; color: #f6f6f6; padding: 5px;">
+
<!-- end #bg -->
-
You are provided with this team page template with which to start the iGEM season.  You may choose to personalize it to fit your team but keep the same "look." Or you may choose to take your team wiki to a different level and design your own wiki.  You can find some examples <a href="https://2008.igem.org/Help:Template/Examples">HERE</a>.
+
<div id="footer">
 +
  <p>&copy;2013 ITU IGEM All Rights Reserved. &nbsp;&bull;&nbsp; Designed by Seda KARABACAK & Mertcan AKYÜREK &nbsp;&bull;&nbsp;
</div>
</div>
-
<div id="warning" style="text-align: center; font-weight: bold; font-size: small; color: #f6f6f6; padding: 5px;">
 
-
You <strong>MUST</strong>  have all of the pages listed in the menu below with the names specified.  PLEASE keep all of your pages within your teams namespace. 
 
-
</div>
 
-
</div>
 
-
</html>
 
-
<!-- *** End of the alert box *** -->
+
</body>
 +
</html>

Revision as of 15:59, 4 October 2013

ITU IGEM

 

Safety

iGEM Safety Form

     As ITU_MOBGAM_Turkey team, safety concerns is our first priority in both developing project and producing the prototype bacteria. Project is developed considering the BSL of our facility which is 1. Member of laboratory crew has been selected on experience. Holding at least one month laboratory experience was criteria for selection. MSDS files of chemicals were studied before using. All experiment carried in a convenient place (laminar hood, regular hood etc.). Waste both biological and organic materials were handled properly.

Offical Safety Form

1. Please describe the chassis organism(s) you will be using for this project. If you will be using more than one chassis organism, provide information on each of them:

Species

Strain No

Risk Group

Risk Group Source Link

Disease risk to humans? If so, which disease?

E.coli

Bl21 (DE3)

1

http://oba.od.nih.gov
/oba/rac/Guidelines/
NIH_Guidelines.htm

Yes. May cause irritation to skin, eyes and respiratory tract, may affect kidneys.

E.coli

(GM2163)

1

http://oba.od.nih.gov
/oba/rac/Guidelines/
NIH_Guidelines.htm

Yes. May cause irritation to skin, eyes and respiratory tract, may affect kidneys.


2. List and describe all new or modified coding regions you will be using in your project. (If you use parts from the 2013 iGEM Distribution without modifying them, you do not need to list those parts.)

Part Number

Where did you get the physical DNA for this part (which lab, synthesis company, etc)?

What species does this part originally come from?

What is the Risk Group of the species?

What is the function of this part, in its parent species?

BBa_K1096000

Synthesized, Integrated DNA Technology

Homo sapiens

1

Binds and transports the B12 vitamine in small intestine

BBa_K1096001

Synthesized, Integrated DNA Technology

E. coli (K12)

1

Inhibits the toxic effect of MazF

BBa_K1096002

Synthesized, Integrated DNA Technology

E. coli (K12)

1

mRNA endoribonuclease

Do the biological materials used in your lab work pose any of the following risks? Please describe.

   a. Risks to the safety and health of team members or others working in the lab?

NO.

   b. Risks to the safety and health of the general public, if released by design or by accident?

NO.

   c. Risks to the environment, if released by design or by accident?

Maybe. Transfer of MazE or MazF plasmid to other bacteria may affect survivability of other bacteria

   d. Risks to security through malicious misuse by individuals, groups, or countries?

NO.

5. If your project moved from a small-scale lab study to become widely used as a commercial/industrial product, what new risks might arise? (Consider the different categories of risks that are listed in parts a-d of the previous question.) Also, what risks might arise if the knowledge you generate or the methods you develop became widely available? (Note: This is meant to be a somewhat open-ended discussion question.)

If the product become widely used in public, contamination may arise in environment due to the plasmid conjugation.

6. Does your project include any design features to address safety risks? (For example: kill switches, auxotrophic chassis, etc.) Note that including such features is not mandatory to participate in iGEM, but many groups choose to include them.

We have two kill switch mechanism for probable risk. One of them decrease risk of contamination of nature. Meanwhile, other one would inhibit overgrowth of bacteria we used.

7. What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available.

Yes. In our bachelor education we have a class name as 'Modern Techniques in Biology'. In that class, first lecture is biosafety training. However, the documents of the lecture is offline.

8. Under what biosafety provisions will / do you work?

   a. Please provide a link to your institution biosafety guidelines.

NONE.

   b. Does your institution have an Institutional Biosafety Committee, or an equivalent group? If yes, have you discussed your project with them? Describe any concerns they raised with your project, and any changes you made to your project plan based on their review.

No. However we discussed our project safety with our project instructor. We choose the strain of E. coli based on this because overgrowth of some strains of E. coli may fatal to human.

   c. Does your country have national biosafety regulations or guidelines? If so, please provide a link to these regulations or guidelines if possible

http://www.turkted.org.tr/mevzuat/kanunlar/Bioguvenlik.htm . The link provides you the biosafety law of Turkey but in turkish.

   d. According to the WHO Biosafety Manual, what is the BioSafety Level rating of your lab? (Check the summary table on page 3, and the fuller description that starts on page 9.) If your lab does not fit neatly into category 1, 2, 3, or 4, please describe its safety features [see 2013.igem.org/Safety for help].

   Biosafety level 1.

 

 



To contact us:

e-mail: igem.itu@gmail.com
Facebook
Twitter

 

 


Home Team Official Team Profile Project Parts Submitted to the Registry Modeling Notebook Safety Attributions


Use this page to answer the questions on the safety page.

Retrieved from "http://2013.igem.org/Team:ITU_MOBGAM_Turkey/Safety"